Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

1 Therapeutic

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
Nuplazid	Pimavanserin, ACP-103, Pimavanserin tartrate	Alzheimer's Disease (Rejected), Schizophrenia (Discontinued), Dementia (Rejected), Depression (Discontinued)	Acadia Pharmaceuticals	Other Neurotransmitters	Small Molecule	Parkinson's psychosis